WCLC 2025 - Posters & ePosters-P3.12.45 Aumolertinib for Treatment-Naïve EGFR-Mutant NSCLC Patients With Brain Metastases: Updated Efficacy Data From the ARTISTRY

P3.12.45 Aumolertinib for Treatment-Naïve EGFR-Mutant NSCLC Patients With Brain Metastases: Updated Efficacy Data From the ARTISTRY

Asset Subtitle

Xiaojuan Zhang

Meta Tag

Speaker Xiaojuan Zhang

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy